X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (42) 42
oncology (41) 41
female (39) 39
index medicus (31) 31
middle aged (23) 23
cancer (19) 19
aged (18) 18
adult (16) 16
immunology (14) 14
prognosis (14) 14
endometrial cancer (13) 13
hematology, oncology and palliative medicine (13) 13
immunotherapy (13) 13
neoplasm staging (13) 13
carcinoma (12) 12
expression (12) 12
obstetrics & gynecology (12) 12
ovarian cancer (12) 12
umcg approved (12) 12
endometrial neoplasms - pathology (10) 10
risk factors (10) 10
survival (10) 10
immunohistochemistry (9) 9
obstetrics and gynecology (9) 9
p53 (9) 9
t-lymphocytes, cytotoxic - immunology (9) 9
aged, 80 and over (8) 8
colorectal-cancer (8) 8
dendritic cells (8) 8
ovarian neoplasms - immunology (8) 8
research (8) 8
cervical cancer (7) 7
chemotherapy (7) 7
endometrial neoplasms - therapy (7) 7
health aspects (7) 7
medicine, research & experimental (7) 7
ovarian neoplasms - pathology (7) 7
treatment outcome (7) 7
amino acid sequence (6) 6
animals (6) 6
care and treatment (6) 6
cervical-cancer (6) 6
cytotoxic t lymphocyte (6) 6
external-beam radiotherapy (6) 6
follow-up studies (6) 6
immunization (6) 6
lymphocytes (6) 6
molecular sequence data (6) 6
ovarian-cancer (6) 6
randomized-trial (6) 6
regulatory t-cells (6) 6
survival analysis (6) 6
t-lymphocytes - immunology (6) 6
tumor (6) 6
tumor suppressor protein p53 - immunology (6) 6
tumor-infiltrating lymphocytes (6) 6
tumors (6) 6
antigens (5) 5
cancer vaccines - immunology (5) 5
endometrial neoplasms - mortality (5) 5
human (5) 5
human papillomavirus (5) 5
lymphocytes, tumor-infiltrating - immunology (5) 5
patients (5) 5
radiotherapy (5) 5
surgery (5) 5
t cells (5) 5
uterine cervical neoplasms - pathology (5) 5
young adult (5) 5
analysis (4) 4
breast-cancer (4) 4
cancer patients (4) 4
cells (4) 4
clinical trials (4) 4
down-regulation (4) 4
endometrial neoplasms - immunology (4) 4
flow cytometry (4) 4
immune-responses (4) 4
immunity, cellular (4) 4
immunogenicity (4) 4
metaanalysis (4) 4
metastasis (4) 4
molecular diagnostics (4) 4
neoplasm grading (4) 4
neoplasm invasiveness (4) 4
netherlands (4) 4
prognostic-significance (4) 4
radiation (4) 4
registries (4) 4
retrospective studies (4) 4
uterine cervical neoplasms - surgery (4) 4
vaccine (4) 4
vaccines (4) 4
wild-type p53 (4) 4
women (4) 4
adenocarcinoma, clear cell - pathology (3) 3
adolescent (3) 3
biochemistry & molecular biology (3) 3
biopsy (3) 3
cancer research (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Cancer, ISSN 0007-0920, 06/2011, Volume 105, Issue 1, pp. 93 - 103
Journal Article
Annals of Oncology, ISSN 0923-7534, 01/2016, Volume 27, Issue 1, pp. 16 - 41
Journal Article
Journal Article
Molecular Imaging and Biology, ISSN 1536-1632, 12/2019
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 08/2017, Volume 146, Issue 2, pp. 380 - 385
Objectives: Compliance of physicians with guidelines has emerged as an important indicator for quality of care. We evaluated compliance of physicians with... 
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1114 - 1126
Summary Background About 15% of patients with endometrial cancer have high-risk features and are at increased risk of distant metastases and endometrial... 
Hematology, Oncology and Palliative Medicine | CARCINOMA PATIENTS | EXTERNAL-BEAM RADIOTHERAPY | GYNECOLOGIC-ONCOLOGY-GROUP | ONCOLOGY | PELVIC RADIATION-THERAPY | EUROPEAN-ORGANIZATION | STAGE-I | OVARIAN-CANCER | INTERMEDIATE-RISK | III TRIAL | CHEMOTHERAPY | Endometrial Neoplasms - radiotherapy | Prognosis | Follow-Up Studies | Humans | Middle Aged | Gastrointestinal Diseases - etiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Adenocarcinoma, Clear Cell - radiotherapy | Chemoradiotherapy, Adjuvant - adverse effects | Nervous System Diseases - diagnosis | Case-Control Studies | Gastrointestinal Diseases - diagnosis | Cisplatin - administration & dosage | Neoplasm Grading | Radiotherapy, Adjuvant - adverse effects | Cystadenocarcinoma, Serous - therapy | Female | Paclitaxel - administration & dosage | Cystadenocarcinoma, Serous - secondary | Neoplasm Invasiveness | Carboplatin - administration & dosage | Survival Rate | Lymphatic Metastasis | Hematologic Diseases - diagnosis | Adenocarcinoma, Clear Cell - secondary | Hematologic Diseases - etiology | Adenocarcinoma, Clear Cell - therapy | Endometrial Neoplasms - therapy | Nervous System Diseases - etiology | Quality of Life | Endometrial Neoplasms - pathology | Aged | Neoplasm Staging | Cystadenocarcinoma, Serous - radiotherapy | Endometrial cancer | Oncology, Experimental | Radiation | Metastasis | Research | Radiotherapy | Health aspects | Risk factors | Cancer
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2015, Volume 26, Issue 10, pp. 2141 - 2149
The immune system is important in epithelial ovarian cancer (EOC). Interleukin-6 is associated with chemoresistance and an immune-suppressive tumor... 
Tumor immunity | Immunotherapy | Chemoresistance | Interleukin-6 | Ovarian cancer | Prognosis | Follow-Up Studies | Adenocarcinoma, Mucinous - pathology | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Receptors, Interleukin-6 - antagonists & inhibitors | Cystadenocarcinoma, Serous - pathology | Adenocarcinoma, Clear Cell - blood | Cystadenocarcinoma, Serous - drug therapy | Dose-Response Relationship, Drug | Neoplasm Recurrence, Local - pathology | Antibodies, Monoclonal, Humanized - administration & dosage | Adenocarcinoma, Mucinous - blood | Interleukin-6 - blood | Doxorubicin - analogs & derivatives | Adult | Female | Adenocarcinoma, Mucinous - drug therapy | Neoplasm Recurrence, Local - blood | Ovarian Neoplasms - drug therapy | Doxorubicin - administration & dosage | Cystadenocarcinoma, Serous - blood | CA-125 Antigen - blood | Enzyme-Linked Immunosorbent Assay | Neoplasm Invasiveness | Carboplatin - administration & dosage | Ovarian Neoplasms - blood | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Biomarkers, Tumor - blood | Interferon-alpha - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Adenocarcinoma, Clear Cell - pathology | Aged | Neoplasm Staging | Endometrial Neoplasms - blood | Interferon-gamma - blood | Adenocarcinoma, Clear Cell - drug therapy | Index Medicus
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 09/2019, Volume 105, Issue 1, pp. S1 - S2
Journal Article
British Journal of Cancer, ISSN 0007-0920, 01/2018, Volume 119, Issue 9, pp. 1067 - 1074
Journal Article
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 08/2017, Volume 146, Issue 2, pp. 327 - 333
The morphological classification of high-risk endometrial cancer is of limited prognostic value. Recent attempts to stratify tumours according to molecular... 
Prognosis | Endometrial cancer | pp63 | Molecular profiling | L1CAM | p21 | Pole | p53 | WORKING | CLASSIFICATION | P63 | EXPRESSION | CARCINOMA | OBSTETRICS & GYNECOLOGY | ONCOLOGY | Immunohistochemistry | Neoplasms, Cystic, Mucinous, and Serous - metabolism | Endometrial Neoplasms - mortality | Adenocarcinoma, Clear Cell - mortality | Humans | Middle Aged | Endometrial Neoplasms - metabolism | Tumor Suppressor Protein p53 - genetics | Carcinoma, Endometrioid - metabolism | Neoplasms, Cystic, Mucinous, and Serous - genetics | Young Adult | Neoplasm Grading | Endometrial Neoplasms - genetics | Phosphoproteins | Aged, 80 and over | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Adult | Female | Proto-Oncogene Proteins c-mdm2 - metabolism | Carcinoma, Endometrioid - genetics | Tumor Suppressor Proteins - metabolism | Neoplasms, Cystic, Mucinous, and Serous - pathology | Signal Transduction | Adenocarcinoma, Clear Cell - metabolism | Neoplasm Invasiveness | Gene Silencing | Proportional Hazards Models | Tumor Suppressor Protein p53 - metabolism | Transcription Factors - metabolism | Carcinoma, Endometrioid - mortality | Cell Line, Tumor | Endometrial Neoplasms - pathology | Adenocarcinoma, Clear Cell - pathology | Aged | Mutation | Adenocarcinoma, Clear Cell - genetics | Carcinoma, Endometrioid - pathology | Neoplasms, Cystic, Mucinous, and Serous - mortality | Tumor proteins | Health aspects | Risk factors | Cancer
Journal Article